Most industrial hemp these days is produced for medical cannabis, whether for local use or to export from the country its grown in. More and more, however, we’re seeing different countries further embrace the other uses of industrial hemp, like for building materials, plastics, clothing, and so on. Ecuador recently joined in on this when it expanded its hemp cultivation and production industry, to cover more industrial uses. Ecuador basicsEcuador is a country in South America that borders the Pacific Ocean to its left, and Colombia and Peru to its northwest and southwest, respectively. Officially known as The Republic of Ecuador, it also includes the Galapagos Islands to its east in the Pacific, an island that became famous for its many varied birds, and Charles Darwin’s research into natural selection. By the 15th century, most of the local indigenous groups of the area had converged into the Inca Empire, until it was colonized by Spain in the 16th century. The country declared its independence in 1820, at that time a part of Gran Colombia (a larger version of Colombia, which split off to form Ecuador, Panama, Venezuela, and parts of Peru, Brazil, and Guyana). It split from here, becoming it own sovereign nation, in 1830. Ecuador is home to close to 18 million people, and while Spanish is the main language, it also has 13 other native languages recognized. Ecuador is considered a developing country, and relies on its farming and petroleum industries, mainly. It holds the 8th largest economy of South America, which puts it in the bottom half, though it did show high growth in the beginning of the century, and is considered an upper-middle-income country. Having said that, it struggles with extreme poverty, with numbers decreasing in the beginning of the century, just to rise to 34.60% in 2020. Thanks for being with us. We offer the Cannadelics Weekly Newsletter for email updates; and to access cool promotions on cannabis buds, vapes, edibles, smoking equipment, cannabinoid compounds (delta-8, HHC), and a wide selection more. Join us here for all your cannabis shopping! Cannabis in EcuadorEcuador might not be as far along as a country like Uruguay (the only Latin American country, aside from Mexico, which has legalized recreational cannabis), but it certainly has made great strides recently when it comes to cannabis; akin to other Latin American countries like Argentina, Colombia, and Costa Rica. In Ecuador, cannabis isn’t legal for recreational use, but there is a decriminalization policy that allows up to 10 grams for personal use. The 2008 Constitution of Ecuador was the first reform policy, and doesn’t stipulate drug use as a crime, but rather a health issue. This was backed up in 2014 with the introduction of new policy by Attorney General Diego Garcia, who stated “the law allows use and does not consider it criminal, but cultivation, trafficking, and sale of little or large amounts of drugs continue to be prohibited.” He did stipulate that “according to the Constitution (article 364), we do not criminalise drug use. We consider it a health problem and not a crime.” In 2014, new legislation passed called the Comprehensive Organic Criminal Code, which updated the section on criminal offenses under the previous Law 108, which was instituted in 1991. Law 108 was noted for it harshness, with punishments up to 10 years for cannabis sales; and the ability to slap crimes together to create bigger sentences of up to 25 years. So, say, you were caught selling, you might also be prosecuted for trafficking, which could mean years more onto the sentence. These new laws set better parameters for the distinction of specific crimes, so that punishments could more correctly fit each crime. For example, it differentiates between large-scale, and small-scale trafficking; rather than prosecuting all trafficking crimes the same way. The law also decriminalized personal cultivation of cannabis, but specifically outlawed growing any psychoactive plants for commercial use. Then, in 2019, the Reform of the Criminal Law, was published, and went into effect in June of 2020. This included reforms like the institution of medical cannabis: “decriminalization of possession of drugs that contain cannabis or derivatives as their active ingredient for therapeutic, palliative or medicinal ends, or for the practice of alternative medicine”. It also amended the Law of Control and Prevention of the use of Drugs, to exclude “non-psychoactive or hemp cannabis from control, extended to the cannabis plant or any part of the plant, whose delta-9-tetrahydrocannabinol (THC) content is less than 1%.” Ecuador’s National Assembly passed the medical cannabis bill with a vote of 82 to 23 (with 23 abstentions). Then President Lenín Moreno had a month to veto the voted-in action, but did not, allowing these measures to pass into law. Together, these reforms regulate cannabis and derivatives for legal medical use. The law gave the Ministry of Agriculture up to 120 days to come up with regulations for the cultivation, importation, production, sale, and export of industrial hemp. ![]() Ecuador and industrial hemp cultivation nowEcuador’s hemp market kicked off in 2022 when it was announced AYA Natural and Medical Products became the first company to gain GMP certification to begin production. That was in March, nearly a year ago. Since then, the country has continued to catapult itself into the industrial hemp global market. However, recently, it made some interesting updates. Reported in early 2023, the Ecuadorian government approved an initiative between two private companies (Green and Growth, Quito; and Nobis Holding de Inversiones) and the Latin-American organization Industrial Hemp Association (LAIHA). As a group, the three will grow between 100 to 1,000 hectares of hemp in Ecuador, at an expense of approximately $25 million, going up to $50 million, starting in 2025. Executive Director of Green and Growth, Jaime Gómez, stated: “Among the main objectives of this initiative is to position the country as one of the economies that join the global commitment to the production of sustainable materials and resources,” and that it “will generate hundreds of jobs.” What’s the difference between this, and what is already cultivated outside the program? Aside from this, pretty much all flower has been grown for export in a medical market. This new partnership is meant to grow hemp for fiber and grain production, to be used in “high-grade materials, such as technical fibers, biochar and other value-added products, for export and stimulation of the national market,” according to the group. Ecuador sure jumped into the world of hemp quickly. Information released by the Ministry of Production, Foreign Trade, Investment and Fisheries last year, stated that up until October, 2022, there were already over 150 cannabis products on the market; all in line with regulation through the National Agency for Health Regulation, Control and Surveillance. Of the more than 150 products, 56% were for cosmetics, 25% for medicinal use, and 19% for food products. As of December 2022, according to the National Registry of Hemp Licensees of the Ministry of Agriculture and Livestock, 169 licenses were given out. What else is Ecuador up to in the world of hemp?This year from February 9-11, Ecuador hosted the Fourth Meeting of Expert Professionals in Phytocannabinoids, put on by Cannamerica. It happened at the Universidad de las Américas campus UDLA Park, in the capital city of Quito. These meetings are in line with the United Nations Sustainable Development Goals for 2030, regarding areas such as health and related issues, education, general industry, and innovation and infrastructure. ![]() For its part, Cannamerica is an international organization that works to establish connections between companies and associations within the industry, with a focus on access and use of medical cannabis. Previous meetings were held in Peru, Chile and Argentina. The event had approximately 50 exhibitors from different countries, who represent expertise in clinical use, as well as research, and the industry in general. The meeting showcased varied professionals within the field of cannabis. This included Eliana Eberle, the Undersecretariat for Productive Innovation Projects for the Ministry of Production, Science and Technology, who presented an agronomic model of cannabis cultivation for climatic conditions like winter; and the provincial Ministry of Health, which expounded on results for the very first survey about medical cannabis, which was administered to health teams. ConclusionAs of right now, there are no specific plans for a recreational legalization in Ecuador, but it wouldn’t be surprising if one came up soon. For now, Ecuador maintains as one of the more forward-thinking countries when it does come to cannabis, with an eye on expanding its industrial hemp market even further. Hello all! Thanks for making your way to Cannadelics.com; where we work daily to bring you independent news for the expanding cannabis and psychedelics fields. Head our way frequently to stay up-to-date on everything important; and sign up to the Cannadelics Weekly Newsletter, so you’re always sure to be ahead of the curve. The post <strong>Ecuador Expanded Hemp Industry to Include More Industrial Uses</strong> appeared first on Cannadelics. Via https://cannadelics.com/2023/02/28/ecuador-expanded-hemp-industry-to-include-more-industrial-uses/
0 Comments
While not every region of the world is onboard yet, many countries are taking advantage of changing opinions toward cannabis, to change legislation for use; as well as start production industries. One of the interesting countries to watch, is Brazil; as it becomes a new cannabis startup capital of the world. A bit about BrazilBefore getting into how Brazil has a huge cannabis startup market, let’s first take a look at the country, and its general weed laws. The Federal Republic of Brazil sits in South America, and takes up most of the land space of that region, covering 3,300,000 square miles (or 8.5 million square kilometers). It has a population of around 215 million making it easily the most populous country in Latin America, and either the 5th or 6th largest country in the world, depending on your source. It’s on the east side of the land mass, and borders from north to south (on its north and west sides): Surinam, Guyana, Venezuela, Colombia, Peru, Bolivia, Paraguay, Argentina, and Uruguay. To the east is the Atlantic Ocean. Unlike the majority of the rest of South America, the national language is Portuguese, not Spanish. The country is classified as both an emerging power and developing country. It has the 12th largest GDP in the world, and the 9th in terms of purchasing power parity. It holds the biggest economy in Latin America. Cool to have you with us. Check out and subscribe to the Cannadelics Weekly Newsletter for email updates; and promotions for cannabis buds, vapes and other equipment, edibles, smoking devices, cannabinoid compounds, and a ridiculous amount more. We’ve got the good stuff; come over and get it! Cannabis in BrazilWhen it comes to cannabis, the plant is illegal for recreational use, but was decriminalized for the possession of small amounts for personal use in 2006. In terms of repercussions, the sale, transport, and trafficking of any drug is a criminal offense, which comes with a prison term of 5-15 years, and fines. Use crimes incur educational support, community service, and for some lucky users, just a warning. In 2015, medical cannabis was legalized in the country with a .2% THC cap for most ailments. It does allow for terminally ill patients without other recourse to receive medications with more than .2% THC. When the legalization first occurred, medications could only be imported into the country. In 2019, this changed, although not completely. The 2019 update did a couple things. For one, it allowed pharmacy sales of cannabis medications. Second, it opened up legality for production of the drugs in Brazil, rather than relying on imports. In order to get a license for these activities, companies are required to obtain a Certificate of Good Manufacturing Practice, which is given out by ANVISA (Brazilian National Agency for Sanitary Surveillance.) CBD also requires a prescription in Brazil, with use strictly controlled by ANVISA. What the law didn’t legalize in 2019, was the cultivation of the plant. Though manufacturing products became legal, it only went as far as manufacturing, which means all raw materials still require import. So while this opened the market further, and made drugs a bit more accessible; it still rules out a vertical market, since domestic cultivation wasn’t legalized on any level. Brazil as the cannabis startup capitalEven without a formal cultivation market, the cannabis industry in Brazil skyrocketed out in the last couple years. It’s expected that only about 41,000 of the current population (over 200 million), uses medical cannabis. This means there’s plenty of room to grow; however it seems the sales market is taking off regardless of use numbers. According to the LatAm Report 2022 via Prohibition Partners, there were over 75,000 instances of medical cannabis imports in 2021 alone, which was up 39% from the previous year. What’s happening to it all? Well, these imports, along with domestic production, are fueling a growing startup industry that covers tons of bases related to cannabis. ![]() Brazilian data company Kaya Mind, reported that when 2022 started, there were 285 companies in the cannabis space, 136 of which register as startup companies. What are they dealing with? Some are geared toward importation of products, and distribution, and marketing. But others are niche industries built to cater to niche issues. Some of the interesting additions include banking startups like Cannapag; veterinary products companies such as Dr. VetCannabis; advocacy services including Rede Reforma; genetics organizations like Adwa; educational companies including CEC; food and beverage manufacturers such as Blue Hemp; cosmetics providers including CBeDifferent; and even cultivation equipment companies like Edroponic. Whereas it used to be company founders making the biggest investments in their own companies, this has changed in the last year. Now companies are picking up large amounts of funding early on from outside investors. How is it all regulated?It’s not. Often when a law passes, such as a legalization, it does so without all (or sometimes any) specifics in place. This is the case here. Production of cannabis products was opened to Brazil, but without regulation to really run the industry. That regulation has, in fact, been argued over since 2020. The law in question is called Bill 399/2015. Originating in the summer of 2020, the bill seeks to legalize cultivation of cannabis within Brazil, along with regulation for the production industry. The original bill was put forth by Deputy Paulo Teixeira to the Chamber of Deputies, with provisions for domestic cultivation; meant to lower import costs and the overall cost of medications. In the summer of 2021, the bill passed the Special Committee of the Chamber of Deputies, and by then included provisions for uses in the regular medical world, as well as veterinary, and industrial uses, along with general cultivation. This passage unfortunately only signaled part of the journey, as after this, it was sent to the Senate. The bill is still in motion. ![]() Though it hasn’t passed yet, a couple other things happened to change the landscape in the past year. The first was a Superior Court of Justice ruling in the case of three medical cannabis patients who wanted to grow cannabis to extract the oil for pain control. All five judges on the panel voted unanimously that this action was okay. Medical cultivation isn’t technically legal in the country. Since there isn’t existing regulation, its expected this ruling will be used in other similar cases until there is. But it also means those cultivating now without a ruling, do risk arrest and prosecution. Said Judge Rogério Schietti, “The discourse against this possibility is moralistic. It often has a religious nature, based on dogmas, on false truths, stigmas. Let us stop this prejudice, this moralism that delays the development of this issue at the legislative, and many times clouds the minds of Brazilian judges.” Recent backward movement?Of course, this goes in contrast to then – president Jair Bolsonaro, who stated the previous year that he was against any authorization for the personal cultivation of cannabis. And while Bolsonaro was voted out last October, he attempted some damage in the interim time between the initial election on October 2nd, and the runoff on October 30th. Although, technically, it wasn’t Bolsonaro that did it. On October 8th, the Federal Council of Medicine (CFM) put out a resolution. The CFM is another regulating body which is capable of revoking cannabis licensing, and which can decide what ailments receive cannabis treatments. In this interim time, the agency started stripping patients of their prescriptions, and limiting the conditions that cannabis can treat. It also banned doctor’s from giving relevant lectures on the topic; which is a very dictatorial move. To give an idea of the mentality of the action, no medical information subsequent to 2015 was used by the CFM to make this decree. The public, however, was uncool with this, as expected. Uncool enough to stop it in its tracks. And considering the timing, they should have been, as it looks quite likely that Bolsonaro was behind it. Perhaps in a last bid effort to have his way, as the public voted him out. Luckily, the president did change over. And it changed to Luiz Inácio da Silva, who is left-wing, and pro-cannabis; making it unlikely that such a decree could remain, and much more likely that Bill 399/2015 (or an equivalent) will eventually go through. Understandably, with everything up in the air at the moment, there hasn’t been an update on bill progress, other than that it awaits an appeal to get sent to the Senate. ![]() ConclusionWith Bolsonaro out of office, and da Silva in office, it’s not probable that cannabis policy will slide back further; and we should expect the same forward progression as before. Eventually, some form of regulation will come out. For now, Brazil stands in an interesting place with its cannabis startup nation; which without regulation, is taking its own form. Welcome one and all! Thanks for finding us at Cannadelics.com; a news site that caters to the growing cannabis and psychedelics industries. Join us whenever possible to keep up with everything going on, and check out the Cannadelics Weekly Newsletter, so you’re never late to get a story. The post Brazil: Cannabis Startup Capital of the World? appeared first on Cannadelics. Via https://cannadelics.com/2023/02/28/brazil-cannabis-startup-capital-of-the-world/ This fight is ongoing. Are all cannabinoids that have to do with hemp, legal? Are hemp-derived cannabinoids that are completely or partially synthetic, legal? Are the cannabinoids that show up in nature, but are only used for production as synthetics, legal? And what about the products that are made from these compounds? Are they legal? There’s a mass amount of confusion on this, and on one end, a pretty discreet answer. So here we ago, when it comes to the DEA and FDA, what’s the difference between legal drugs, and legal products? DEA, FDA, and USDA: what do these government agencies do?For the most part, we have a generally good idea about this, but just to be clear, let’s quickly go over on a broad scale, the purpose (and power) of these government agencies. We’ll start with the DEA. According to the agency, “The mission of the Drug Enforcement Administration (DEA) is to enforce the controlled substances laws and regulations of the United States and bring to the criminal and civil justice system of the United States, or any other competent jurisdiction, those organizations and principal members of organizations, involved in the growing, manufacture, or distribution of controlled substances appearing in or destined for illicit traffic in the United States.” On another hand, according to the FDA, “The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation.” Cool that you stopped by. Check out the Cannadelics Weekly Newsletter to get your direct email updates; and tons of deals on cannabis flowers, vapes and equipment, edibles, smoking devices, cannabinoid compounds, and a host more. Get all your cannabis-related shopping done here! It goes on, “FDA also has responsibility for regulating the manufacturing, marketing, and distribution of tobacco products to protect the public health and to reduce tobacco use by minors.” And, “is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health.” As the FDA controls the regulation of all tobacco products, as stated, this includes vapes. Vapes are currently regulated under tobacco law, meaning all usage of vapes (e-cigarettes) falls under FDA regulation as electronic nicotine delivery systems (ENDS). As far as the USDA, “We provide leadership on food, agriculture, natural resources, rural development, nutrition, and related issues based on public policy, the best available science, and effective management. We have a vision to provide economic opportunity through innovation, helping rural America to thrive; to promote agriculture production that better nourishes Americans while also helping feed others throughout the world; and to preserve our Nation’s natural resources through conservation, restored forests, improved watersheds, and healthy private working lands.” These three agencies all play a role with cannabis in some way. The USDA regulates industrial hemp cultivation; the DEA regulates the legality of drug compounds; and the FDA regulates cannabis in products like foods, cosmetics, medicines, and supplements. These designations are important when looking at the controversy over the cannabinoid industry (and the cannabis industry as a whole), and the idea of legal drugs vs legal products. The part of the USDAThere is a huge argument right now over which cannabis compounds are legal, and which products are legal; and these two questions are fundamentally different, because they’re governed by different agencies. So, to get an idea how it works with cannabis, let’s go over the breakdown between the legality of one vs the other. To start with, the USDA’s 2018 Farm Bill legalized the cultivation of industrial hemp. And set a definition for ‘hemp’, which is the basis for a huge, and ongoing, argument, over exactly what this refers to; particularly in the case of wholly synthetic, or partially synthetic compounds. The ambiguity is partly related to the US not having a general definition for ‘natural’, meaning, there are no definitions for other thing like ‘naturally-derived’ either. Such a term is often used to greenwash products (make them sound more natural than they are), which has led to multiple lawsuits. ![]() There is more specific regulation on this front in terms of food, however, with organic laws setting particular standards. And with organizations like the ISO (International Organization for Standardization) which set standards for cosmetics and food. Apart from offering the hemp definition that causes so many problems (on one front), the USDA is less involved in the rest of the argument. Legal cannabis drugs vs legal cannabis products, which is DEA and which is FDA? USDA aside, the DEA regulates drugs on behalf of the Department of Justice. It holds drug scheduling lists that determine the legality and uses of a drug on a federal level. Schedule I is for 100% illegal drugs with no accepted medical use, a high risk of danger, and a high risk of addiction. These drugs are illegal for any resident to possess, use, cultivate, sell, transport, traffic, or do anything else with. Cannabis is one of these drugs. However, recently, plants with no more than .3% THC were legalized by the most recent farm bill, for industrial use; by moving regulation for cultivation and production (only) to the USDA. When we want to know if a drug is legal in general, we look to the DEA. And that’s why the agency has fielded inquires, like from the Alabama Board of Pharmacy about delta-8, and more recently, by attorney Rod Kight in terms of two synthetic cannabinoids: Delta-9-THCO and delta-8-THCO. In both cases, it stipulated they’re illegal. These questions are about overall legality, like, can I have it at all as a legal compound, or will simply having it be a federal offense. But that’s where DEA control ends. The problem with the current debate, is that its essentially over products, rather than standard legality. Whether the DEA says the compounds are legal or not, has 100% no bearing on whether they’re legal to use in products. And that’s because the FDA (NOT the DEA) overseas all uses of cannabis in anything related to medical, supplements, cosmetics, smoking, and food products. This means anything dealing with cannabis in vapes, is illegal. As is every other kind of cannabis product: oils and tinctures (both supplements, or food), creams, patches, and makeup (cosmetics, or medicine), pills, and treatments of any kind (medicine or supplements). They’re all uniformly illegal; because the FDA never made them legal. What does the FDA permit? “With the exception of Epidiolex, Marinol, and Syndros, no product containing cannabis or cannabis-derived compounds (either plant-based or synthetic) has been approved as safe and effective for use in any patient population, whether pediatric or adult.” ![]() If it needs to be stated more clearly, this ends the question of whether any cannabis product is legal on a federal level. And the answer is no. Once again, this is unrelated to whether the DEA classifies something as illegal or not. In fact, it should be remembered that the DEA has cannabis in Schedule I, yet the FDA approved Epidiolex, Marinol, and Syndros. Which means an illegal drug can still be used in legal products, should the FDA pass them. And a legal drug, is still illegal in products, if the FDA doesn’t make an allowance. Why do people try to use DEA answers to promote product legality? Hard for me to say, but I have my theories. One of them is simply confusion. I fully admit I, myself, was quite entangled in the ‘synthetic or not’ aspect of the argument for a long time. And that still matters in terms of legal drugs, but it doesn’t affect legal products. At least not in current circumstances. When an industry has regulation through different government bodies for the same topic, it can get confusing. And for many, it might seem like the DEA holds the answers to issues of product legality. The other possibility is more a manipulation issue. The ideas generally focused on when speaking of the debate on hemp-derived cannabinoids, are whether they cross the .3% THC level at any point in processing, and whether they’re synthetic to some degree and what that means. That’s because these things can be argued. What is less arguable, is that the agency that allows legal products, never changed its stance. If industry promoters and vendors had the public focus on this, their products would be seen as illegal with no recourse. If response letters from the FDA were published, there wouldn’t be a question. This is similar to how I believe the government uses methods of subterfuge to keep American attention off certain topics. Whether the cannabinoid industry is dirty or not, it simply doesn’t come with any real death toll that can be attributed to anything but additives. As in, not any of the cannabinoids, synthetic or not, have caused an issue to any real degree. On the other hand, while the government talks of them like they’re a massive threat to humanity, it continues to push opioids through regulation, as they now kill close to 100 thousand people a year. Same concept. By focusing on the DEA, and whether a drug is legal overall, takes attention away from the fact that the FDA regulates products, and the DEA has nothing to do with this. The cannabinoid products industry isn’t going to focus on the legal aspect that renders it completely illegal. It’s going to focus on the debatable part, and sell it products based on the argument therein. Final thoughts I really don’t care if the products market continues. I mean, it’s a bit gross, with trademark violations, fake labs, mislabeled products, and no way to know what’s added in. But legal markets tend to have these issues too. And realistically, they ain’t killing anyone. My argument is simply about understanding the legal landscape, and not falling victim to subterfuge marketing moves when it comes to this understanding. But am I parading around for the end of cannabinoids? No. And realistically, illegal or not, there seem to be few, if any, repercussions involved; likely because the US can’t fight another losing drug war. ![]() I’d sure love if everyone had access to the real plant (which seems to lower use of synthetics anyway), but I also know people like to get high and will try what’s available. And if its not going to cause damage, or at least, not in remotely the same ballpark as other drugs like medically approved opioids and benzodiazepines, and illegal ones like meth; it kind of seems like the FDA should suck it up, and allow it to happen. Although, in the world of reality, the market continues regardless. Hey guys, welcome! Thanks for making it to Cannadelics.com; where we work to bring you independent coverage of the cannabis and psychedelics industries, everyday. Head our way whenever possible to keep updated on everything important; and subscribe for our Cannadelics Weekly Newsletter, so you’re always on top of what’s going on. The post DEA & FDA: The Confusion Over Legal Drugs VS Legal Products appeared first on Cannadelics. Via https://cannadelics.com/2023/02/27/dea-fda-the-confusion-over-legal-drugs-vs-legal-products/ The High Times Hemp Cup is an annual competition where hemp cultivators, processors, and brands around the country submit their products for a chance to win the title of the best hemp-derived product. The judge kits are distributed across the country for consumers to test and judge each product inside of their kit. This year, the competition has become more interesting as new psychedelic product has made its debut in the competition, the Amanita HHC Gummies, the Amanita Delta 8 Joint and the Amanita CBD Joint, all from Amanita Muscaria mushroom, a legal trending psychedelic product, sold online. Click HERE to see the new additions to 2023 High Times Hemp Cup competition: Introducing Amanita HHC Gummies & Amanita Delta 8 JointThe new Amanita HHC Gummies are lab-tested 25mg HHC gummies dipped in Amanita Muscaria mushroom chocolate. The Amanita CBD mushroom joint is made from amanita infused organic indoor hemp flower, and the Amanita Delta 8 THC mushroom caviar joint contains Amanita + Delta 8 infused hemp flower blend with Muscaria powder coating on the outside, with a total of 500mg. Al three products are produced by PsiloMart which becomes the first legal magic mushroom company to submit entries for the 2023 High Times Hemp Cup. The company believes that there is an entourage effect between cannabis and mushrooms that needs to be explored, which led them to create a new “Amanita +” line of Muscimol mushroom products blended with hemp-derived cannabinoids. Since the Hemp Cup is the “People’s Choice” edition, we need to wait and see what will be the score given to these products. However, the inclusion of these Amanita Muscaria products in the High Times Hemp Cup competition is a testament to the high demand expected for blended cannabis and psychedelic products. The new Amanita mushroom productsThe new Amanita Hemp Cup products include Amanita HHC gummies, Amanita Delta 8 THC joint, and Amanita CBD joints. These products are also available for purchase directly from the supplier, with the option to use the “Cannadelics” coupon code to save an additional 20%. Amanita HHC GummiesOne of the Amanita + products submitted to the 2023 High Times Hemp Cup is the Amanita + HHC Magic Mushroom Gummies. These lab-tested gummies contain 25 mg of HHC, a simplified version of THC, and are dipped in Amanita Muscaria mushroom chocolate. The combination of HHC and muscimol from Amanita Muscaria mushrooms creates a unique experience for users. Amanita HHC Gummies
Buy Amanita HHC gummies(With Cannadelics coupon code)Amanita CBD Joint and Amanita Delta 8 JointsAnother two product submitted to Hemp Cup are the Amanita CBD joints and the Amanita Delta 8 joints. The Amanita + CBD Mushroom Joints, include Amanita Pantherina powder blended with organic indoor hemp flower for a total of 250 mg. The Amanita Delta 8 joint features a blend of Amanita + Delta 8-infused hemp flower with muscaria powder coating on the outside for a total of 500 mg. This product is the more potent one, as it includes both Delta 8 THC and Amanita Muscaria extract, both psychoactive. Amanita Delta 8 THC Joints
Buy Amanita Delta 8 THC Joints(With Cannadelics coupon code)Thank you for stopping in. Head over to our weekly newsletter, the Cannadelics Sunday Edition for a weekly digest of our best stories, and get access to the best cannabis and psychedelic products! Simply write your email below: Keep yourself updated with the latest Amanita HHC gummies, as well as more cannabis and psychedelic products:
|
ABOUT MEHallo, ik ben Rosalina Klerkx, ik ben een RHIA-gecertificeerde zorgbeheerder met meer dan 6 jaar ervaring in het creëren van een productieve omgeving voor zorgprofessionals. Leiding gegeven aan een team van 12 opname- en verkoopmedewerkers in een instelling voor langdurige zorg met meer dan 170 patiënten. Opstellen van complexe HIPAA-conforme rapporten aan patiëntendienstcoördinatoren in een zorgkliniek. Archives
April 2023
Categories |